{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:17:14Z","timestamp":1773285434560,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clbc.2019.01.008","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T23:24:13Z","timestamp":1548890653000},"page":"e428-e432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prophylactic Versus Therapeutic Mastectomy: A Contemporary Analysis of the ACS-NSQIP Database"],"prefix":"10.1016","volume":"19","author":[{"given":"Ryan J.","family":"Hendrix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Kristin","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Rouanet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne C.","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"LaFemina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2019.01.008_bib1","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969-2014), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released March 2016. Available at: https:\/\/seer.cancer.gov\/data\/citation.html, Accessed: February 22, 2018."},{"key":"10.1016\/j.clbc.2019.01.008_bib2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ejso.2016.04.054","article-title":"Contralateral risk reducing mastectomy in patients with sporadic breast cancer. Benefits and hazards","volume":"42","author":"Boccardo","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2019.01.008_bib3","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1200\/JCO.2005.06.217","article-title":"Patient involvement in surgery treatment decisions for breast cancer","volume":"23","author":"Katz","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.01.008_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamasurg.2014.2895","article-title":"Nationwide trends in mastectomy for early-stage breast cancer","volume":"150","author":"Kummerow","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clbc.2019.01.008_bib5","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1245\/s10434-009-0547-9","article-title":"Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution","volume":"16","author":"Jones","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2019.01.008_bib6","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.2008.16.0275","article-title":"Contralateral prophylactic mastectomy: mind the genetics","volume":"26","author":"Briasoulis","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.01.008_bib7","first-page":"55","article-title":"Conservative mastectomies for breast cancer and risk-reducing surgery: the Memorial Sloan Kettering Cancer Center experience","volume":"5","author":"Manning","year":"2016","journal-title":"Gland Surg"},{"key":"10.1016\/j.clbc.2019.01.008_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2019.01.008_bib9","first-page":"CD002748","article-title":"Prophylactic mastectomy for the prevention of breast cancer","volume":"11","author":"Lostumbo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clbc.2019.01.008_bib10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/cncr.11702","article-title":"Coagulopathic complications in breast cancer","volume":"98","author":"Caine","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2019.01.008_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V62.1.14.14","article-title":"Activation of blood coagulation in cancer: Trousseau\u2019s syndrome revisited","volume":"62","author":"Rickles","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.clbc.2019.01.008_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.sla.0000193832.40178.0a","article-title":"Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways","volume":"243","author":"Andtbacka","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2019.01.008_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(01)00619-2","article-title":"Cancer and the prothrombotic state","volume":"3","author":"Lip","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2019.01.008_bib14","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1245\/s10434-008-0151-4","article-title":"Venous thromboembolism in cancer patients undergoing major surgery","volume":"15","author":"Osborne","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2019.01.008_bib15","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1182\/blood-2010-06-293126","article-title":"Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis","volume":"116","author":"McEachron","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clbc.2019.01.008_bib16","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jvs.2011.10.129","article-title":"Variation in thromboembolic complications among patients undergoing commonly performed cancer operations","volume":"55","author":"De Martino","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.clbc.2019.01.008_bib17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00432-012-1161-y","article-title":"Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers","volume":"138","author":"Custodio","year":"2012","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.clbc.2019.01.008_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/bcr1871","article-title":"Tissue factor, angiogenesis and tumour progression","volume":"10","author":"Bluff","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2019.01.008_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2012-0322","article-title":"Tissue factor as a novel target for treatment of breast cancer","volume":"18","author":"Cole","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2019.01.008_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2011-06-317685","article-title":"The relationship between tissue factor and cancer progression: insights from bench and bedside","volume":"119","author":"van den Berg","year":"2012","journal-title":"Blood"},{"issue":"suppl 2","key":"10.1016\/j.clbc.2019.01.008_bib21","article-title":"Assessment of angiogenesis in the hyperplasia preinvasive, invasive breast carcinoma sequence","volume":"10","author":"Bluff","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2019.01.008_bib22","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0959-8049(97)00360-2","article-title":"Should prophylactic surgery be used in women with a high risk of breast cancer?","volume":"33","author":"Klijn","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2019.01.008_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5858\/2000-124-0378-PMPFIH","article-title":"Prophylactic mastectomy: pathologic findings in high-risk patients","volume":"124","author":"Khurana","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clbc.2019.01.008_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13058-015-0650-8","article-title":"Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women","volume":"17","author":"Evans","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2019.01.008_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s13058-014-0442-6","article-title":"The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services","volume":"16","author":"Evans","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2019.01.008_bib26","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1055-9965.EPI-09-0171","article-title":"Uptake of risk reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age and time dependent","volume":"18","author":"Evans","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919300503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919300503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:31Z","timestamp":1761513511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820919300503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1526820919300503"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2019.01.008","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic Versus Therapeutic Mastectomy: A Contemporary Analysis of the ACS-NSQIP Database","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2019.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}